Actualités de London

Filtre
  • 17.05.2022 – 09:02

    FNZ

    FNZ makes investment in GIST to accelerate sustainable investing globally

    Boston and London (ots/PRNewswire) - - GIST is a pioneering impact data and analytics company that provides investors and companies with science-based, comparable and verifiable measures of corporate impact and performance. - FNZ's investment follows the launch of its market-leading sustainable investment solution, FNZ Impact, which enables financial institutions to ...

  • 16.05.2022 – 14:01

    Johnson Matthey

    Johnson Matthey publishes latest PGM Market Report, 2022

    London (ots/PRNewswire) - The platinum market should move closer to balance in 2022, according to Johnson Matthey's latest PGM Market Report. This provides an overview of demand for platinum group metals in 2021 and an outlook for 2022, in advance of the annual London Platinum & Palladium Market week. Platinum demand growth will be driven by rising consumption in catalysts for heavy duty trucks, and increased use of ...

  • 16.05.2022 – 10:16

    BELKIN Vision

    BELKIN Vision's Eagle™ Receives CE Mark under MDR

    Yavne, Israel (ots/PRNewswire) - Accessible First-Line Contactless Glaucoma Care Now Available in Europe BELKIN Vision, the Israel-based medical device company committed to bringing an accessible first-line glaucoma laser treatment to market, announced today that it has been awarded CE Mark under Medical Device Regulation (MDR) from its notified body DEKRA, making it the first automated, non-contact glaucoma laser ...

  • 29.04.2022 – 19:43

    Hikma Pharmaceuticals PLC

    Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals

    London (ots/PRNewswire) - Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary to a PR Newswire announcement issued today indicating that Opiant Pharmaceuticals and Hikma have entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK. About Hikma ...

  • 29.04.2022 – 12:17

    nShift

    nShift reveals 58% of customers will abandon a business due to a poor customer experience

    London (ots/PRNewswire) - Owning the end-to-end shopping experience can significantly increase conversion rates, according to nShift Online retailers are losing out on a significant amount of revenue to customers dissatisfied with the experience they offer, with 70 percent of all online shopping carts abandoned prior to checkout.1 Some 58% of customers will stop doing ...

  • 26.04.2022 – 10:02

    News Direct

    Image Analyzer Extends Technology Partnership with OpenText

    London (ots) - --News Direct-- Image Analyzer, vendor of award-winning visual threat recognition technology, has announced an extended Technology Supply Agreement with OpenText™, a global leader in Information Management and leading provider of digital forensic software. Under the terms of the agreement, OpenText has integrated Image Analyzer Visual Intelligence System (IAVIS) into its OpenText™ Magellan™ Risk Guard ...

  • 26.04.2022 – 09:31

    AMS

    AMS bolsters Board as global expansion continues

    London (ots/PRNewswire) - Global provider of talent outsourcing and advisory services, AMS (formerly Alexander Mann Solutions), has appointed two new Directors, Jacqueline Welch and Franck Cohen, to its Board as it continues its strong growth trajectory. Jacqueline Welch, Executive Vice President and Chief Human Resources Officer at The New York Times, brings with her a wealth of relevant experience in senior talent roles ...

  • 18.04.2022 – 13:43

    XTX Markets

    /DISREGARD RELEASE: XTX Markets/

    London (ots/PRNewswire) - We are advised by XTX Markets that journalists and other readers should disregard the news release, XTX Markets one of the first companies to remove employees' household carbon emissions, issued 18-Apr-2022 over PR Newswire. [User Fills Optional Text Detailing Reason for Kill] Contact: Tim Moxon - Global Head of Marketing/Communications, +44 203 198 3300, ...